NCT05296980 · RECRUITING

Validation of the REMINDER Dementia Risk Reduction Program

This trial is testing a behavioral program called REMINDER against a brain health education class. REMINDER combines personal development coaching, memory aids, goal-setting, and behavior change techniques. Researchers want to know whether it improves cognitive and brain health outcomes over time compared to basic psychoeducation. This is a validation trial — not a drug study, and not yet a proven or approved intervention. Details on long-term results are still being gathered.

You may qualify if

  • Age 60 or older
  • CAIDE dementia risk score >8
  • Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED
  • Free of physical disabilities that preclude participation in the study
  • Willing to complete all study-related activities for 12 weeks

You're excluded if

  • Mild cognitive impairment or dementia;
  • Presence of any neurological event in their medical history that could compromise actual cognition.
  • Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria).
  • Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group.
  • Illiteracy

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-05-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials